Paper · 42909883

Exon-6 truncated p53 Suppresses Innate Immune Responses to Facilitate Immune Evasion in Bladder Cancer.

Zhang C and 15 others. Int J Biol Sci, 2026.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Exon-6 truncated p53 Suppresses Innate Immune Responses to Facilitate Immune Evasion in Bladder Cancer. Papers, record 42909883. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42909883

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Exon-6 truncated p53 Suppresses Innate Immune Responses to Facilitate Immune Evasion in Bladder Cancer.
Journal: Int J Biol Sci
Year: 2026
Publication types: Journal Article, Research Support, Non-U.S. Gov't
PubMed: https://pubmed.ncbi.nlm.nih.gov/42909883/
DOI: https://doi.org/10.7150/ijbs.131491
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC13685605/
The journal: https://conductscience.org/library/journal-index/101235568
Revised in PubMed: 2026-10-25

Source PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Zhang C	Chi
2	Wei W	Wenjie
3	Cao S	Senming
4	Li Z	Zhi
5	Wang C	Chuang
6	Tao W	Wen
7	Dong Y	Yuhao
8	Liu C	Chunyu
9	Wu S	Shun
10	Tian S	Shuo

1 to 10 of 16Source PubMed

See all 16 authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Urinary Bladder Neoplasms	Major topic
Tumor Suppressor Protein p53	Major topic
Immunity, Innate	Major topic
Immune Evasion	Major topic
Humans
Animals
Protein Serine-Threonine Kinases
Cell Line, Tumor
Signal Transduction
Exons
Mice
Interferon Type I

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References50

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	29,443,960	TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.	Nature	2018	https://conductscience.org/library/papers/29443960	PubMed
2	37,667,466	Type I interferon and cancer.	Immunol Rev	2024	https://conductscience.org/library/papers/37667466	PubMed
3	32,164,908	Toll-like Receptors and the Control of Immunity.	Cell	2020	https://conductscience.org/library/papers/32164908	PubMed
4	25,636,800	Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation.	Science	2015	https://conductscience.org/library/papers/25636800	PubMed
5	39,120,546	Multi-Metallic Nanosheets Reshaping Immunosuppressive Tumor Microenvironment through Augmenting cGAS-STING Innate Activation and Adaptive Immune Responses for Cancer Immunotherapy.	Adv Sci (Weinh)	2024	https://conductscience.org/library/papers/39120546	PubMed
6	38,900,212	p53 protein expression patterns associated with TP53 mutations in breast carcinoma.	Breast Cancer Res Treat	2024	https://conductscience.org/library/papers/38900212	PubMed
7	40,552,295	The activation of cGAS-STING pathway offers novel therapeutic opportunities in cancers.	Front Immunol	2025	https://conductscience.org/library/papers/40552295	PubMed
8	28,988,769	Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.	Cell	2017	https://conductscience.org/library/papers/28988769	PubMed
9	20,182,602	TP53 mutations in human cancers: origins, consequences, and clinical use.	Cold Spring Harb Perspect Biol	2010	https://conductscience.org/library/papers/20182602	PubMed
10	40,118,736	European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines.	Eur Urol	2025	https://conductscience.org/library/papers/40118736	PubMed

1 to 10 of 50

See all 50 references

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first.

None in this release.

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data1

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bank	Accession
GEO	GSE308506

Source GEO

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42909883

GET https://conductscience.org/api/papers/v1/42909883/references?page=2

API reference For AI assistants